Financial Express runs a commentary on the Indian Initiative for Open Source Drug Discovery for neglected diseases.
If you thought the adoption of open source was restricted to only software—web servers, code development, and operating systems— then think again. The open source wave could soon power drug discovery initiatives in the country. A decentralised, web-based initiative is emerging that would enable scientists from laboratories, universities, institutes, and drug Companies to work together in discovering new drugs for diseases like tuberculosis (TB), malaria, various types of cancer, AIDS, Chikungunya, Kala-azar, dengue fever, etc. Not only would drugs be made available to the public at affordable prices, there are monetary gains for the participating researchers in the form of awards and prizes.
Open source drug discovery would have independent biologists freely sharing their work through the internet.
Saturday, May 3, 2008
India Takes an Open Source Approach to Drug Discovery | Cell, Vol 133, 201-203, 18 April 2008
Cell Press covers the Indian Initiative on Open Source Drug Discovery in an Analysis article authored by Seema Singh.
The article in short summarizes the concept of Open Source Drug Discovery for neglected diseases, especially Tuberculosis.
The full-text article is available only for registered users and can be found
Comment on this article on Cell Press website.